Nemaura Medical Future Growth
Future criteria checks 2/6
Nemaura Medical's earnings are forecast to decline at 20.8% per annum while its annual revenue is expected to grow at 214.5% per year. EPS is expected to decline by 19.1% per annum.
Key information
-20.8%
Earnings growth rate
-19.1%
EPS growth rate
| Medical Equipment earnings growth | 16.2% |
| Revenue growth rate | 214.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 22 Feb 2024 |
Recent future growth updates
Recent updates
Nemaura Medical GAAP EPS of -$0.17
Aug 15Nemaura Medical GAAP EPS of -$0.59 misses by $0.12, revenue of $0.51M
Jun 30Nemaura Medical: Opportunity In The Consumer-Centered Continuous Glucose Monitoring Market
Mar 10Nemaura Medical (NASDAQ:NMRD) Has Debt But No Earnings; Should You Worry?
Nov 17
Nemaura Medical: From Believer To Skeptic
Sep 20Nemaura: Wearable Monitoring Patches For Type-2 Diabetics Could Be An Inspired Move
Jul 02Nemaura Medical rallies on 200K sugarBEAT sensors order
May 05Nemaura Medical: Lowering Glucose Levels Will Increase Share Price
Feb 03How Much Of Nemaura Medical Inc. (NASDAQ:NMRD) Do Insiders Own?
Dec 22
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2025 | 1 | -13 | N/A | -11 | 1 |
| 3/31/2024 | 0 | -9 | N/A | -7 | 1 |
| 12/31/2023 | N/A | -11 | -10 | -10 | N/A |
| 9/30/2023 | 0 | -10 | -10 | -10 | N/A |
| 6/30/2023 | 0 | -13 | -9 | -9 | N/A |
| 3/31/2023 | 0 | -14 | -9 | -8 | N/A |
| 12/31/2022 | 0 | -13 | -9 | -8 | N/A |
| 9/30/2022 | 1 | -15 | -8 | -8 | N/A |
| 6/30/2022 | 1 | -14 | -8 | -7 | N/A |
| 3/31/2022 | 1 | -14 | -7 | -7 | N/A |
| 12/31/2021 | 0 | -12 | -7 | -6 | N/A |
| 9/30/2021 | N/A | -10 | -8 | -6 | N/A |
| 6/30/2021 | N/A | -9 | -8 | -7 | N/A |
| 3/31/2021 | N/A | -6 | -7 | -6 | N/A |
| 12/31/2020 | N/A | -5 | -6 | -6 | N/A |
| 9/30/2020 | N/A | -4 | -5 | -5 | N/A |
| 6/30/2020 | N/A | -4 | -4 | -4 | N/A |
| 3/31/2020 | N/A | -4 | -4 | -3 | N/A |
| 12/31/2019 | N/A | -4 | -4 | -4 | N/A |
| 9/30/2019 | N/A | -5 | -4 | -4 | N/A |
| 6/30/2019 | N/A | -5 | -4 | -4 | N/A |
| 3/31/2019 | N/A | -4 | -4 | -4 | N/A |
| 12/31/2018 | N/A | -3 | -3 | -3 | N/A |
| 9/30/2018 | N/A | -3 | -3 | -3 | N/A |
| 6/30/2018 | N/A | -2 | -2 | -2 | N/A |
| 3/31/2018 | N/A | -2 | -2 | -2 | N/A |
| 12/31/2017 | N/A | -2 | -2 | -2 | N/A |
| 9/30/2017 | N/A | -2 | N/A | -2 | N/A |
| 6/30/2017 | N/A | -1 | N/A | -1 | N/A |
| 3/31/2017 | N/A | -2 | N/A | -1 | N/A |
| 12/31/2016 | N/A | -2 | N/A | -1 | N/A |
| 9/30/2016 | N/A | -2 | N/A | -1 | N/A |
| 6/30/2016 | N/A | -2 | N/A | -1 | N/A |
| 3/31/2016 | N/A | -2 | N/A | -1 | N/A |
| 12/31/2015 | N/A | -2 | N/A | -1 | N/A |
| 9/30/2015 | N/A | -1 | N/A | -1 | N/A |
| 6/30/2015 | N/A | -1 | N/A | -1 | N/A |
| 3/31/2015 | N/A | -1 | N/A | -1 | N/A |
| 12/31/2014 | N/A | -1 | N/A | 0 | N/A |
| 9/30/2014 | N/A | -1 | N/A | 1 | N/A |
| 6/30/2014 | N/A | -1 | N/A | 1 | N/A |
| 3/31/2014 | N/A | -1 | N/A | 2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NMRD is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NMRD is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NMRD is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NMRD's revenue (214.5% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: NMRD's revenue (214.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NMRD's Return on Equity is forecast to be high in 3 years time